Abstract:Objective:To investigate the effects of a disintegrin and metalloprotease 10 (ADAM10) on coronary artery in-stent restenosis (ISR) in diabetes.Methods:Rapamycin-eluting stents were implanted in the coronary arteries of 17 diabetic and 10 normal minipigs, and angiography was repeated after 6 months.The coronary artery tissues of significant ISR and non-ISR segments in both diabetic and normal minipigs were analyzed by western blot analysis to detect the expression of ADAM10.Overexpression and konckdown of ADAM10 were transfected by retrovirus in human aortic smooth muscle cells (HASMC).The proliferation of HASMC was measured by BrdU assay and migration was detected by scratch test.The ADAM10 expressions of HASMC were analyzed by real time RT-PCR and western blot after treatment with low glucose, high glucose, advanced glycation end products-bovine serum albumin (AGE-BSA), and AGE-BSA+receptor for AGE (RAGE) antibody.Results:The results showed that the expressions of ADAM10 in both non-ISR tissues (3.36±1.27 vs.2.11±2.05,P<0.01) and ISR tissues (10.48±4.72 vs.6.72±1.36,P<0.01) were significantly higher in diabetic minipigs than those in normal minipigs.ADAM10 levels were significantly increased in ISR tissues compared with non-ISR tissues in both normal minipigs and diabetic minipigs (both P<0.01).BrdU assay showed that The proliferation of HASMC with overexpre-ssion of ADAM10 increased in both low glucose culture (2.25±0.07 vs.1.87±0.08, P<0.05) and high glucose culture (2.47±0.10 vs.2.07±0.10, P<0.05) compared with that of HASMC transfected by empty vector, while the proliferation of HASMC with knockdown of ADAM10 significantly inhibited in both low glucose culture (1.34±0.10 vs.1.87±0.08, P<0.05) and high glucose culture (1.46±0.09 vs.2.07±0.10, P<0.05) compared with that of HASMC transfected by empty vector.The cell proliferation in high glucose culture was significantly higher than that in low glucose culture both in HASMC with overexpression and knockdown of ADAM10 (both P<0.05).Cell scratch test showed that the cell migration distances were significantly longer in HASMC with overexpression of ADAM10 compared with HASMC transfected by empty vector both in low glucose culture [(1.02±0.12) mm vs.(0.65±0.04) mm, P<0.05)] and high glucose culture [(1.26±0.06) mm vs.(0.78±0.06) mm, P<0.05)], while those were shorter in HASMC with knockdown of ADAM10 compared with HASMC transfected by empty vector both in low glucose culture [(0.26±0.06) mm vs.(0.65±0.04) mm, P<0.05)] and high glucose culture [(0.43±0.14) mm vs.(0.78±0.06) mm, P<0.05)].The cell migration distance in high glucose culture was significantly longer than that in low glucose culture both in HASMC with overexpression and knockdown of ADAM10 (both P<0.05).The relative expressions of ADAM10 mRNA and protein were significantly higher in high glucose culture and AGE-BSA than those in low glucose culture (all P<0.05), while significantly lower in AGE-BSA+RAGE antibody than those in AGE-BSA (both P<0.05).Conclusions:ADAM10 expression is significantly increased in coronary artery ISR segments of diabetes.Increased ADAM10 expression promotes the proliferation and migration of arterial smooth muscle cells.High glucose and AGE can both induce the expression of ADAM10.ADAM10 may be involved in the development and progress of diabetic ISR.

Increase Of Adam10 Level In Coronary Artery In-Stent Restenosis Segments In Diabetic Minipigs: High Adam10 Expression Promoting Growth And Migration In Human Vascular Smooth Muscle Cells Via Notch 1 And 3

EFFECTS OF A DISINTEGRIN AND METALLOPROTEASE 10 ON CORONARY ARTERY IN-STENT RESTENOSIS WITH DIABETES

Two-Dimensional Fluorescence In-Gel Electrophoresis of Coronary Restenosis Tissues in Minipigs

Increment of HFABP Level in Coronary Artery In-Stent Restenosis Segments in Diabetic and Nondiabetic Minipigs: HFABP Overexpression Promotes Multiple Pathway-Related Inflammation, Growth and Migration in Human Vascular Smooth Muscle Cells

Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway

Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine

Elevation of Tumor Necrosis Factor-Alpha, Interleukin-1 Beta and Interleukin-6 Levels in Aortic Intima of Chinese Guizhou Minipigs with Streptozotocin-Induced Diabetes

Effect of Rapamycin Eluting Stent for Inhibition of Neointimal Hyperplasia in Diabetic Porcine Model

ADAM10 Alleviates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Activating the Notch Signaling Pathway

Essential Role of Pin1 Via Stat3 Signalling and Mitochondria-Dependent Pathways in Restenosis in Type 2 Diabetes

ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation

ADAM33 Silencing Inhibits Vascular Smooth Muscle Cell Migration and Regulates Cytokine Secretion in Airway Vascular Remodeling via the PI3K/AKT/mTOR Pathway

Effect of Angiopoietin-Related Protein 2 on Coronary Angiogenesis and Myocardial Function in a Porcine Model of Acute Myocardial Ischemia

Modulation of miR-29a and ADAM12 Reduces Post-Ischemic Skeletal Muscle Injury and Improves Perfusion Recovery and Skeletal Muscle Function in a Mouse Model of Type 2 Diabetes and Peripheral Artery Disease

FSTL1-USP10-Notch1 Signaling Axis Protects Against Cardiac Dysfunction Through Inhibition of Myocardial Fibrosis in Diabetic Mice

Abstract 5494: ADAMTS-7 is Critical for Vascular Smooth Muscle Cell Migration and Neointima Formation in Injured Rat Carotid Artery

Establishment of Diabetes Peripheral Arterial Disease Model of Minipig

Abstract 17568: Phospholipase C Gamma-1 Mediated Akt-notch1 Signaling is Essential for Intima Formation

ADAM17: A novel treatment target for aneurysms

Protective role of arachidonic acid against diabetic myocardial ischemic injury: a translational study of pigs, rats, and humans

Protein disulfide isomerase-mediated apoptosis and proliferation of vascular smooth muscle cells induced by mechanical stress and advanced glycosylation end products result in diabetic mouse vein graft atherosclerosis